Shandra Eisenga Human Cell and Tissue Product Safety Act

Jun 24, 2025

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jun 23, 2025

Motion to reconsider laid on the table Agreed to without objection.

Jun 23, 2025

DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.

Jun 23, 2025

Considered under suspension of the rules. (consideration: CR H2860-2862)

Jun 23, 2025

Mr. Bilirakis moved to suspend the rules and pass the bill.

Jun 23, 2025

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)

Jun 23, 2025

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)

Jun 12, 2025

Reported by the Committee on Energy and Commerce. H. Rept. 119-160.

Jun 12, 2025

Placed on the Union Calendar, Calendar No. 127.

Jun 12, 2025

Reported by the Committee on Energy and Commerce. H. Rept. 119-160.

Apr 29, 2025

Committee Consideration and Mark-up Session Held

Apr 29, 2025

Ordered to be Reported by Voice Vote.

Feb 6, 2025

Introduced in House

Feb 6, 2025

Referred to the House Committee on Energy and Commerce.

Feb 6, 2025

Introduced in House

HR 1082Shandra Eisenga Human Cell and Tissue Product Safety Act